Atypical benign partial epilepsy of childhood with acquired neurocognitive, lexical semantic, and autistic spectrum

Nicholas M Allen1, Judith Conroy2, Thierry Deonna3

  • 1Department of Paediatrics, National University of Ireland Galway & Galway University Hospital, Ireland; Department of Paediatric Neurology and Clinical Neurophysiology, Temple Street Children's University Hospital, Dublin 1, Ireland.

Insights

Atypical benign partial epilepsy (ABPE) in children can cause acquired neurodevelopmental issues. This study links ABPE to specific genetic variants and resulting oromotor and cognitive deficits.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neurogenetics

Background:

  • Atypical benign partial epilepsy (ABPE) of childhood, or pseudo-Lennox syndrome, is an idiopathic focal epilepsy.
  • ABPE presents with diverse seizures, epileptiform discharges, and potential neurocognitive deficits.
  • Limited data exists on longitudinal follow-up and genetic underpinnings of ABPE-associated deficits.

Purpose of the Study:

  • To conduct a phenotype-genotype study of a child with ABPE.
  • To detail the longitudinal progression of neurocognitive, language, and motor deficits in relation to epilepsy.
  • To investigate potential genetic variants contributing to ABPE and associated disorders.

Main Methods:

  • Longitudinal clinical follow-up of a pediatric patient with ABPE from ages 5 to 13 years.
  • Detailed assessment of oromotor, language, social-communicative, and motor deficits.
  • Whole exome sequencing to identify genetic variants.

Main Results:

  • The patient exhibited acquired oromotor deficits and later developed specific lexical-semantic and pervasive developmental disorders.
  • Exome sequencing revealed variants in SCN9A, CPA6, and SCNM1 genes.
  • A direct causal relationship between the epilepsy and the observed neurocognitive deficits was evident.

Conclusions:

  • This case highlights the significant neurodevelopmental impact of ABPE.
  • Genetic variants in SCN9A, CPA6, and SCNM1 may play a role in ABPE pathogenesis.
  • Further research is needed to elucidate the molecular inheritance patterns in ABPE and related epilepsy aphasia disorders.

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.6K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
719